SELLERI, Carmine

SELLERI, Carmine  

Dipartimento di Medicina, Chirurgia e Odontoiatria “Scuola Medica Salernitana”/DIPMED  

Mostra records
Risultati 1 - 20 di 330 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autore(i) File
2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 1-gen-2020 Salvatore, B; Fonti, R; De Renzo, A; Pellegrino, S; Ferrara, Il; Mainolfi, Cg; Marano, L; Selleri, C; Pane, F; Del Vecchio, S; Pace, L
3D Biomimetic Scaffold for Growth Factor Controlled Delivery: An in-vitro study of Tenogenic events on Wharton’s Jelly Mesenchymal stem cells 1-gen-2021 Ciardulli, M. C.; Lovecchio, J.; Scala, P.; Lamparelli, E. P.; Dale, T. P.; Giudice, V.; Giordano, E.; Selleri, C.; Forsyth, N. R.; Maffulli, N.; Della Porta, G.
3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential 1-gen-2022 Lamparelli, Erwin Pavel; Ciardulli, Maria Camilla; Giudice, Valentina; Scala, Pasqualina; Vitolo, Rosa; Dale, Tina Patricia; Selleri, Carmine; Forsyth, Nicholas Robert; Maffulli, Nicola; Della Porta, Giovanna
67 KDa laminin receptor (67LR) expression and function in normal and acute myeloid leukemia CD34(+) cells 1-gen-2007 Selleri, Carmine; Ricci, F; Cerciello, G; Cuccurullo, R; Camera, A; Giusto, R; Pesapane, A; Ragno, Pia; Rossi, G; Rotoli, B; Montuori, N.
67 KDA laminin receptor (67LR) in normal and neoplastic hematopoietic cells: is its targeting a feasible approach? 1-gen-2016 Montuori, N; Pesapane, A; Giudice, V; Serio, B; Rossi, Fw; De Paulis, A; Selleri, Carmine
67 KDA laminin receptor expression in human G-CSF mobilized CD34(+) peripheral blood stem cells correlates with their mobilization efficiency 1-gen-2007 Selleri, Carmine; Ricci, P; Cerciello, G; Cuccurullo, R; Ferrara, Il; Vitello, M; Rotoli, B; Ragno, Pia; Rossi, G; Montouri, N.
67 kDa laminin receptor: structure, function and role in cancer and infection. 1-gen-2012 Rea, Ve; Rossi, Fw; De Paulis, A; Ragno, Pia; Selleri, Carmine; Montuori, N.
A backwards evolution in a case of myeloproliferative disease 1-gen-2008 Ciancia, R; Ricci, P; Fabbricini, R; Gravetti, A; Izzo, B; Quarantelli, F; Selleri, Carmine; Pane, F; Martinelli, V; Rotoli, B.
A candidate complement inhibitor for the treatment of paroxysmal nocturnal haemoglobinuria (PNH): preclinical data with tt30, a therapeutic that selectively blocks the complement alternative pathway. 1-gen-2010 Pascariello, C; Selleri, Carmine; Del Vecchio, L; Hovarth, Cj; Holers, Vm; Risitano, A. M.
A GITMO randomised trial in steroid refractory acute graft-versus-host disease: 6methylprednisolone with or without anti-thymocyte globulin 1-gen-2004 van Lint, Mt; Uderzo, C; Milone, G; Scime, R; Dallorso, S; Locasciulli, A; Guidi, S; Sica, S; Cudillo, L; Fagioli, F; Selleri, Carmine; Raiola, Am; Dominietto, A; Bacigalupo, A.
A novel approach to cell targeted complement inhibition in PNH: the human complement receptor 2/Factor H fusion protein TT30 prevents both hemolysis and upstream C3-opsonization of PNH erythrocytes 1-gen-2010 Pascariello, C; Selleri, Carmine; Del Vecchio, L; Sica, M; Horvath, C; Holers, M.
A novel chromosomal abnormality detected in a case of acute myelomonocytic leukemia. 1-gen-1994 Fiorillo, A; Sebastio, L; Del Vecchio, L; Migliorati, R; De Chiara, C; D'Amore, R; Vicari, L; Pastore, A; Selleri, Carmine
A randomized trial of bone marrow (BM) versus peripheral blood (PB) allogeneic hemopoietic stem cell transplants (HSCT) in patients with myeloproliferative disorders. 1-gen-2006 Bacigalupo, A; van Lint, Mt; Olivieri, A; Casini, M; Angelucci, E; Narni, F; Selleri, Carmine; Di Bartolomeo, P; Ciceri, F; Fanin, R.
A severe and consistent deficit in marrow and circulating primitive hematopoietic cells (long-term culture-initiating cells) in acquired aplastic anemia. 1-gen-1996 Maciejewski, Jp; Selleri, Carmine; Sato, T; Anderson, S; Young, Ns
Accelerated and persistent bone loss after autologous and allogeneic stem cell transplantation 1-gen-2013 Serio, B; Pezzullo, L; Fontana, R; Annunziata, S; Rosamilio, R; Ferrara, I; Rocco, M; Giudice, V; De Rosa, G; Ricci, P; Montuori, N; Selleri, Carmine
Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3. 1-gen-2011 Risitano, Am; Perna, F; Selleri, Carmine
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study. 1-gen-2019 Bonifazi, F; Solano, C; Wolschke, C; Sessa, M; Patriarca, F; Zallio, F; Nagler, A; Selleri, C; Risitano, Am; Messina, G; Bethge, W; Herrera, P; Sureda, A; Carella, Am; Cimminiello, M; Guidi, S; Finke, J; Sorasio, R; Ferra, C; Sierra, J; Russo, D; Benedetti, E; Milone, G; Benedetti, F; Heinzelmann, M; Pastore, D; Jurado, M; Terruzzi, E; Narni, F; Völp, A; Ayuk, F; Ruutu, T; Kröger, N.
Acute promyelocytic leukemia following myelodysplasia and Fanconi-like syndrome 1-gen-1999 S., Rocco; L., Catalano; Selleri, Carmine; M., Picardi; L., Luciano; B., Rotoli
Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI) 1-gen-2021 Guglielmelli, P.; Palandri, F.; Selleri, C.; Cilloni, D.; Mendicino, F.; Mazza, P.; Pastore, D.; Palumbo, G. A.; Santoro, M.; Pavone, V.; Impera, S.; Morelli, M.; Coco, P.; Valsecchi, D.; Passamonti, F.; Breccia, M.
Adjuvant treatment of diabetic foot 1-gen-2012 Lo Pardo, D; Pezzuti, G; Selleri, Carmine; Pepe, Stefano; Esposito, Silvano